Jeffrey Epstein Inquired About Toxic Plant for Drug Blocking Free Will
Emails reveal that Jeffrey Epstein inquired about a toxic plant known to produce a drug that blocks free will.
15 related stories
Emails reveal that Jeffrey Epstein inquired about a toxic plant known to produce a drug that blocks free will.
Coca-Cola Europacific Partners has released its financial results for the fourth quarter.
Canaccord Genuity Group has announced its third-quarter earnings.
Dye & Durham has released its financial results for the second quarter.
Klaviyo highlights its platform evolution with accelerating revenue and international growth.
Robert Reich highlights that Tesla paid no federal income tax while Elon Musk could earn significantly more than U.S. teachers, raising questions about corporate taxation.
Sinch AB (publ) announced its GAAP EPS of SEK 0.31 and net sales of SEK 6.76 billion for the fourth quarter.
Stabilis Solutions expects its fourth-quarter revenue to fall within the range of $13 million to $13.5 million.
Basilea Pharmaceutica AG announced its GAAP EPS of CHF 3.14 and revenue of CHF 232.4 million for the fourth quarter.

BHP Group, the world's largest miner, saw its shares jump after its copper pivot resulted in a surprise dividend bump and a record-high stock price.
HIVE Digital Technologies announced record third-quarter revenue, driven by its ongoing expansion efforts in Paraguay.
Enlight Renewable Energy reported fourth-quarter GAAP EPS and revenue that both missed analyst expectations.
Knife River reported better-than-expected GAAP EPS and revenue for the fourth quarter.
Hillman Solutions announced its fourth-quarter non-GAAP EPS in-line with expectations, but revenue missed estimates.

The head of Turkey's National Intelligence Organization (MIT), Ibrahim Kalın, stated that the agency took preemptive steps to prevent new security threats from emerging in Syria.